Latest News

February 10, 2012
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and UCSF.
February 10, 2012
Scientists at the San Francisco VA Medical Center and the University of California, San Francisco have published a study showing that one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, tenofovir, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time. See accompanying news release, Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage.
December 21, 2011
In perhaps the most comprehensive survey of the inner workings of HIV, an international team of scientists led by researchers at UCSF has mapped every apparent physical interaction the virus makes with components of the human cells it infects — work that may reveal new ways to design future HIV/AIDS drugs.
December 14, 2011
Scientists at the Gladstone Institutes have discovered new protein fragments in semen that enhance the ability of HIV, the virus that causes AIDS, to infect new cells—a discovery that one day could help curb the global spread of this deadly pathogen.
November 30, 2011
As we mark World AIDS Day this week, the U.S. Centers for Disease Control (CDC) and Prevention reports that more than a million Americans now live with the disease, and every year some 50,000 people in the United States alone are newly infected.
November 30, 2011
A cheaper laboratory test that helps guide anti-retroviral drug treatment for people with HIV/AIDS may be just as effective as a more sophisticated test, a group of international researchers has found – a discovery that could be particularly important in rural Africa.
November 07, 2011
Low level HIV viremia – the presence of HIV in the bloodstream at levels undetectable by standard tests – was not associated with increased blood markers of inflammation or coagulation, or with increased risk of death, in adults taking highly active anti-retroviral therapy (HAART) for HIV infection, in a study led by researchers at the San Francisco VA Medical Center and UCSF.
October 25, 2011
The U.S. Health Resources and Services Administration has funded the UCSF Center for AIDS Prevention Studies to provide leadership and support to seven states implementing interventions to enhance HIV testing and diagnosis.
August 26, 2011
The UCSF team came in third place overall in AIDS Walk San Francisco 2011 raising $55,000 in the annual event to benefit HIV/AIDS programs and services in the San Francisco Bay Area.
July 19, 2011
The UCSF team showed its spirit in the 25th Annual AIDS Walk San Francisco, which drew more than 25,000 walkers and raised more than $3 million to benefit HIV/AIDS programs and services in the Bay Area.

Pages